These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19132558)

  • 1. Cerebrovascular complications of methamphetamine abuse.
    Ho EL; Josephson SA; Lee HS; Smith WS
    Neurocrit Care; 2009; 10(3):295-305. PubMed ID: 19132558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics of Fatal Methamphetamine-related Stroke: A National Study.
    Darke S; Lappin J; Kaye S; Duflou J
    J Forensic Sci; 2018 May; 63(3):735-739. PubMed ID: 28833107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of echocardiographic findings in young adults with cardiomyopathy: with and without a history of methamphetamine abuse.
    Ito H; Yeo KK; Wijetunga M; Seto TB; Tay K; Schatz IJ
    Clin Cardiol; 2009 Jun; 32(6):E18-22. PubMed ID: 19330818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke and methamphetamine use in young adults: a review.
    Lappin JM; Darke S; Farrell M
    J Neurol Neurosurg Psychiatry; 2017 Dec; 88(12):1079-1091. PubMed ID: 28835475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and outcomes of methamphetamine-associated intracerebral hemorrhage.
    Swor DE; Maas MB; Walia SS; Bissig DP; Liotta EM; Naidech AM; Ng KL
    Neurology; 2019 Jul; 93(1):e1-e7. PubMed ID: 31142634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Cardiovascular Diseases and Stroke Events in Methamphetamine Users: A 10-Year Follow-Up Study.
    Huang MC; Yang SY; Lin SK; Chen KY; Chen YY; Kuo CJ; Hung YN
    J Clin Psychiatry; 2016 Oct; 77(10):1396-1403. PubMed ID: 27574836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fatal case of pontine hemorrhage related to methamphetamine abuse.
    Miyashita T; Hayashi T; Ishida Y; Tsuneyama K; Kimura A; Kondo T
    J Forensic Leg Med; 2007 Oct; 14(7):444-7. PubMed ID: 17720598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in CYP2D6 may predict methamphetamine related heart failure.
    Sutter ME; Gaedigk A; Albertson TE; Southard J; Owen KP; Mills LD; Diercks DB
    Clin Toxicol (Phila); 2013 Aug; 51(7):540-4. PubMed ID: 23855716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methamphetamine abuse and rhabdomyolysis in the ED: a 5-year study.
    Richards JR; Johnson EB; Stark RW; Derlet RW
    Am J Emerg Med; 1999 Nov; 17(7):681-5. PubMed ID: 10597089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced bilateral ischemic infarction in an amphetamine addict.
    Christensen MR; Lesnikova I; Madsen LB; Rosendal I; Banner J
    Forensic Sci Med Pathol; 2013 Sep; 9(3):458-61. PubMed ID: 23504704
    [No Abstract]   [Full Text] [Related]  

  • 11. Methamphetamine-associated cardiomyopathy.
    Won S; Hong RA; Shohet RV; Seto TB; Parikh NI
    Clin Cardiol; 2013 Dec; 36(12):737-42. PubMed ID: 24037954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methamphetamine use is an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage.
    Moon K; Albuquerque FC; Mitkov M; Ducruet AF; Wilson DA; Crowley RW; Nakaji P; McDougall CG
    J Neurointerv Surg; 2015 May; 7(5):346-50. PubMed ID: 24780822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methamphetamine-Associated Congestive Heart Failure: Increasing Prevalence and Relationship of Clinical Outcomes to Continued Use or Abstinence.
    Sliman S; Waalen J; Shaw D
    Cardiovasc Toxicol; 2016 Oct; 16(4):381-9. PubMed ID: 26661075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine abuse and dentistry.
    Hamamoto DT; Rhodus NL
    Oral Dis; 2009 Jan; 15(1):27-37. PubMed ID: 18992021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine abuse: a review of the literature and case report in a young male.
    Naidoo S; Smit D
    SADJ; 2011 Apr; 66(3):124-7. PubMed ID: 21874893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology.
    Kaye S; Darke S; Duflou J; McKetin R
    Addiction; 2008 Aug; 103(8):1353-60. PubMed ID: 18855825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine and its impact on dental care.
    Klasser GD; Epstein J
    J Can Dent Assoc; 2005 Nov; 71(10):759-62. PubMed ID: 16324229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methamphetamine abuse: medical and dental considerations.
    Smart RJ; Rosenberg M
    J Mass Dent Soc; 2005; 54(2):44-6, 48-9. PubMed ID: 16149403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methamphetamine and cardiovascular pathology: a review of the evidence.
    Kaye S; McKetin R; Duflou J; Darke S
    Addiction; 2007 Aug; 102(8):1204-11. PubMed ID: 17565561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and Autopsy Characteristics of Fatal Methamphetamine Toxicity in Australia.
    Darke S; Duflou J; Lappin J; Kaye S
    J Forensic Sci; 2018 Sep; 63(5):1466-1471. PubMed ID: 29193063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.